FOGHORN THERAPEUTICS INC.
500 Technology Square, Ste 700
Cambridge, MA 02139
October 20, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attention: | Courtney Lindsay, Celeste Murphy, Division of Corporation Finance, Office of Life Sciences | |
| Re: | Foghorn Therapeutics Inc. Registration Statement on Form S-1 (File No. 333-249264) Request for Acceleration | |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Foghorn Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:30 p.m. Eastern Time on October 22, 2020, or as soon as possible thereafter. The Company hereby authorizes Marc Rubenstein or Rachel Phillips of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Rachel Phillips of Ropes & Gray LLP, counsel to the Company, at (212) 841-8857 as soon as the registration statement has been declared effective.
[Signature page follows]
| Very truly yours, | ||
| FOGHORN THERAPEUTICS INC. | ||
| By: | /s/ Adrian Gottschalk | |
| Name: | Adrian Gottschalk | |
| Title: | Chief Executive Officer | |
[Signature Page to Acceleration Request]